Pelthos Therapeutics (PTHS) Earnings Date & Reports
Pelthos Therapeutics Inc is a biopharmaceutical company committed to commercializing safe and efficacious therapeutic products to help patients with unmet treatment burdens... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
PTHS is expected to report earnings to fall 83.50% to -50 cents per share on August 24
Q2'26
Est.
$-0.51
Q1'26
Missed
by $2.58
Q4'25
Missed
by $6.33
The last earnings report on May 14 showed earnings per share of -308 cents, missing the estimate of -50 cents. With 1.50K shares outstanding, the current market capitalization sits at 101.77M.